11:01 AM EDT, 10/16/2024 (MT Newswires) -- Perspective Therapeutics ( CATX ) said Wednesday it has started shipping its investigational radiopharmaceutical therapies from a recently acquired manufacturing facility in Somerset, New Jersey.

The company said it expects the facility to meet future clinical trial and commercial demands at major cancer treatment centers throughout the northeastern US.

Shares of Perspective Therapeutics ( CATX ) were up nearly 3% in recent trading.

Price: 12.90, Change: +0.33, Percent Change: +2.67